Xenetic Biosciences, Inc. (XBIO)
NASDAQ: XBIO · Real-Time Price · USD
3.140
+0.040 (1.29%)
Jun 6, 2025, 2:38 PM - Market open
Xenetic Biosciences Market Cap
Xenetic Biosciences has a market cap or net worth of $4.84 million as of June 6, 2025. Its market cap has decreased by -16.51% in one year.
Market Cap
4.84M
Enterprise Value
-497.01K
1-Year Change
-16.51%
Ranking
Category
Stock Price
$3.14
Market Cap Chart
Since June 30, 2016, Xenetic Biosciences's market cap has decreased from $47.70M to $4.84M, a decrease of -89.85%. That is a compound annual growth rate of -22.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2025 | 4.80M | -22.58% |
| Dec 31, 2024 | 6.20M | 16.98% |
| Dec 29, 2023 | 5.30M | 23.26% |
| Dec 30, 2022 | 4.30M | -75.14% |
| Dec 31, 2021 | 17.30M | 35.16% |
| Dec 31, 2020 | 12.80M | 54.22% |
| Dec 31, 2019 | 8.30M | -46.10% |
| Dec 31, 2018 | 15.40M | -7.78% |
| Dec 29, 2017 | 16.70M | -53.09% |
| Dec 30, 2016 | 35.60M | -25.37% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 688.18B |
| Johnson & Johnson | 372.39B |
| AbbVie | 336.43B |
| Novo Nordisk | 324.15B |
| UnitedHealth Group | 272.31B |
| Abbott Laboratories | 233.12B |
| Novartis AG | 230.96B |
| AstraZeneca | 225.55B |